Drugs To Combat Anemia In Cancer Patients Increase Risk Of Death, University of Alberta Study Suggests

ScienceDaily (May 7, 2009) — The use of drugs to encourage red blood cell formation (erythropoiesis-stimulating agents) in cancer patients with anemia increases the risk of death and serious adverse events such as blood clots, found a new study in the Canadian Medical Association Journal (CMAJ).